The Board granted an effective date of February 26, 2016, for the grant of service connection for left lower extremity (LLE) sciatic nerve radiculopathy but denied an earlier effective date for the grant of service connection for fibromyalgia.
The deciding factor: The first recorded findings of radiculopathy were in February 2016, and symptoms consistent with fibromyalgia were not factually ascertainable until a February 26, 2022, VA examination.
- Claimed conditions
- left lower extremity (LLE) sciatic nerve radiculopathy, fibromyalgia
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 20%
- Decision date
- March 18, 2025
- Citation
- A25024606
What this means for you
A partial grant means some issues were granted while others were denied or remanded — common in multi-issue claims. Look at which issues went which way, and how each was argued.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Partly granted
The Board granted service connection for scarring, right orchiopexy and remanded the claim of asbestos exposure residuals. Other claims for service connection were denied.
- Partly granted
The Board granted service connection for asthma and remanded claims for insomnia and sleep apnea. Other conditions were denied.
- Dismissed
The Veteran withdrew the appeals for service connection for fibromyalgia and Gulf War unexplained chronic multi-symptom illness, bronchus, as well as an extension of the temporary 100 percent disability evaluation.
- Denied
The Board denied service connection for fibromyalgia as the evidence does not support a current diagnosis of the condition.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.